Stay updated on OV101 in Fragile X Syndrome: Clinical Trial
Sign up to get notified when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.

Latest updates to the OV101 in Fragile X Syndrome: Clinical Trial page
- Check3 days agoChange DetectedThe study record page now shows a 403 Forbidden message replacing the content and provides a Home link, indicating restricted access to the study details.SummaryDifference17%

- Check10 days agoChange DetectedRevision updated in the Study Documents section from v3.6.6 to v3.7.0. This appears to be a metadata/version control update and does not modify the study data, eligibility criteria, outcomes, or other substantive content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe study record now lists Ovid Therapeutics Inc. as sponsor and attaches Healx AI to Ovid Therapeutics Inc. as a collaborator (replacing a standalone Healx AI entry). This reflects a reorganization of the study's organizational affiliations.SummaryDifference0.3%

- Check24 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6. This reflects a small on-page update to versioning information.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a new page build. This indicates an internal update to the page template or content management system rather than a modification to study details or user-facing information.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, reflecting a new page revision in the system.SummaryDifference0.1%

Stay in the know with updates to OV101 in Fragile X Syndrome: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.